Cellestis

Cellestis Limited is an Australian public company with operations in the United States (Cellestis Inc. located in Valencia, CA), Europe (Cellestis GmbH located in Darmstadt, Germany) and Australia (Cellestis International located in Melbourne, VIC). Cellestis Ltd is listed on the Australian Stock Exchange under the code CST. Cellestis develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune (CMI) responses of T cell lymphocytes using whole blood samples. This unique technology provides accuracy and sensitivity, along with major savings in operator time, labour and reagents compared to other means of measuring CMI.

Service : IRM Corporate Website Visit Site : http://www.cellestis.com/